Asprosin is a relatively recently discovered hormone that plays a role in energy regulation, appetite, and glucose metabolism. It is produced primarily by adipose tissue and released into the bloodstream during fasting.
Asprosin acts as a signal that energy is needed. It stimulates glucose release from the liver and influences appetite through central signaling in the brain.
In modern metabolic disease, asprosin levels are often elevated. This suggests that asprosin may contribute to insulin resistance, increased appetite, and the broader metabolic environment associated with obesity and metabolic syndrome.
Asprosin is a peptide hormone derived from a larger precursor protein produced in adipose tissue.
It is involved in:
Asprosin functions as part of the hormonal system that coordinates energy balance, particularly during fasting states.
Asprosin is released into the bloodstream and acts on multiple target organs.
In the liver, it stimulates the release of glucose into the circulation.
In the brain, it activates appetite-regulating pathways.
These actions help ensure that the body maintains adequate energy availability during periods of fasting.
Physiological effects of asprosin include:
Under normal conditions, this system helps maintain metabolic stability.
Asprosin levels typically rise during fasting and fall after food intake.
This pattern reflects its role as a signal of energy need:
This cycle helps regulate meal timing and energy balance.
Asprosin acts on the brain, particularly in regions involved in appetite regulation.
It stimulates hunger signaling pathways and may enhance the drive to eat. This places asprosin in functional contrast with hormones such as leptin, which signal energy sufficiency.
In modern environments with constant food availability, persistent or elevated appetite signaling can contribute to excess caloric intake.
Elevated asprosin levels have been observed in individuals with:
In these settings, asprosin may contribute to metabolic dysfunction by:
This suggests that asprosin may play a role in the development or maintenance of insulin resistance.
Adipose tissue is the primary source of asprosin.
As fat mass increases, particularly in central obesity, circulating asprosin levels may rise. This reflects the broader endocrine role of adipose tissue in metabolic regulation.
This creates a potential feedback loop:
increased adipose tissue
→ increased asprosin production
→ increased appetite and glucose output
→ further metabolic strain
This loop may contribute to the persistence of metabolic syndrome.
Asprosin has direct effects on the liver.
It stimulates hepatic glucose release, particularly during fasting. In metabolic disease, this effect may become exaggerated, contributing to:
This links asprosin to the broader pattern of hepatic involvement in metabolic syndrome.
Elevated asprosin levels have been associated with:
These associations suggest that asprosin is part of the hormonal network that contributes to chronic metabolic dysfunction.
Asprosin does not act alone, but interacts with other signals such as:
Together, these signals shape appetite, energy balance, and metabolic regulation.
Asprosin is an active area of research.
Current studies are exploring:
Because it was identified relatively recently, its full role in human metabolism is still being defined.

Asprosin is a fasting-induced hormone that links adipose tissue, liver, and brain in the regulation of energy balance.
When chronically elevated, it may contribute to:
Asprosin is best understood as part of the broader hormonal network that drives metabolic syndrome and chronic metabolic disease.
© 2026 All copyright reserved. Published with Ghost and Electronthemes